|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002871,
umls-concept:C0021149,
umls-concept:C0035648,
umls-concept:C0087111,
umls-concept:C0280274,
umls-concept:C0332281,
umls-concept:C0524910,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2006-10-11
|
|
pubmed:abstractText |
One major side effect of combination antiviral therapy is the development of anemia, which is more severe among the Asian population. We conducted this large-scaled study to explore the incidence, risk factors, and impact on treatment response of anemia in chronic hepatitis C patients receiving combination antiviral therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1478-3223
|
|
pubmed:author |
pubmed-author:ChangKuo-ChinKC,
pubmed-author:ChangchienChi-SinCS,
pubmed-author:ChenChien-HungCH,
pubmed-author:HuTsung-HuiTH,
pubmed-author:HungChao-HungCH,
pubmed-author:KeeKwong-MingKM,
pubmed-author:LeeChuan-MoCM,
pubmed-author:LuSheng-NanSN,
pubmed-author:TsengPo-LinPL,
pubmed-author:WangJing-HoungJH,
pubmed-author:YenYi-HaoYH
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1079-86
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17032408-Age Factors,
pubmed-meshheading:17032408-Anemia,
pubmed-meshheading:17032408-Antiviral Agents,
pubmed-meshheading:17032408-Body Weight,
pubmed-meshheading:17032408-Drug Therapy, Combination,
pubmed-meshheading:17032408-Female,
pubmed-meshheading:17032408-Hemoglobins,
pubmed-meshheading:17032408-Hepatitis C, Chronic,
pubmed-meshheading:17032408-Humans,
pubmed-meshheading:17032408-Incidence,
pubmed-meshheading:17032408-Interferon-alpha,
pubmed-meshheading:17032408-Male,
pubmed-meshheading:17032408-Middle Aged,
pubmed-meshheading:17032408-Platelet Count,
pubmed-meshheading:17032408-Polyethylene Glycols,
pubmed-meshheading:17032408-Proportional Hazards Models,
pubmed-meshheading:17032408-Recombinant Proteins,
pubmed-meshheading:17032408-Ribavirin,
pubmed-meshheading:17032408-Risk Factors,
pubmed-meshheading:17032408-Severity of Illness Index,
pubmed-meshheading:17032408-Sex Factors,
pubmed-meshheading:17032408-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Anemia associated with antiviral therapy in chronic hepatitis C: incidence, risk factors, and impact on treatment response.
|
|
pubmed:affiliation |
Division of Hepatogastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
|
|
pubmed:publicationType |
Journal Article
|
